Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Organised by the Council on Basic Science: Inspire a new generation of basic cardiovascular science leaders taken from among the most gifted science and medical graduates - Provide opportunities to meet face-to-face role models from an expert faculty of successful cardiovascular scientists.
• Inspire a new generation of cardiovascular science leaders taken from among the most gifted science and medical graduates • Provide opportunities to meet face-to-face with individual members of the expert faculty of successful cardiovascular scientists • Provide opportunities to meet face-to-face with representatives from industry and understand better how scientific discovery can be translated into patient benefit • Give examples of how cardiovascular science has advanced in key areas and has impacted on clinical practice • Identify major challenges for the next generation • Impart insights into those theoretical aspects of pathophysiology, pharmacology, molecular biology and genomics of cardiacS and vascular diseases necessary to underpin a selection of future challenges • Open up a broader perspective on the issues necessary for implementation of research findings in medical practice • Increase confidence among young scientists as investigators and communicators • Promote networking between young scientists throughout Europe
Mainly early stage researchers (PhD and MD/PhD students in the first three years of their research) plus a few more experienced researchers whose PhD degree was obtained within the last 2 years. Delegate numbers limited to 70.
All delegates bring a poster of their research, which is on display throughout the Summer School programme.
Giuseppina Caligiuri (FR), Jolanda van der Velden (NL), Jérémy Fauconnier (FR) and Gemma Vilahur (ES) representing the Scientists of Tomorrow
18.00 Welcome – Course Directors18.15 Opening keynote plenary lecture Jörg Menche (Vienna - Austria) Network modelling and analysis in cardiovascular disease
19.15 Cocktail dinner
Session 1: Cardioprotection09.00 Key pathways to ischemia-reperfusion injury Sean Davidson (London - United Kingdom)09.45 Opportunities and challenges in translating cardioprotection to the clinic Gemma Vilahur (Barcelona - Spain)
10.30 Coffee break – poster areaSession 2: Thrombosis and coagulation11.00 Control of thrombosis and fibrinolysis in vivo: implications for new therapies Nicola Mutch (Aberdeen, United Kingdom) 11.45 Novel oral anticoagulants: mechanisms of action and therapeutic indications Raffaele de Caterina (Chieti, Italy) 12.30 Lunch Boxes – Poster Area- Meet the facultySession 3: Cardiac and vascular development10.30 Fluid flow and heart development Nadia Mercader (Madrid, ES)11.15 Origins of vascular smooth muscle cells and implications for disease Sanjay Sinha (Cambridge, United Kingdom)
15.00 Short breakSession 4: Publishing your research15.15 Getting the experimental design and statistical analysis right Dirk Duncker (Rotterdam)16.00 Writing the paper: what the journal editors expect Karin Sipido (Leuven, Belgium; Editor in Chief, Cardiovascular Research)
17.00-18.30 Refreshments - Poster area – Meet the faculty and exhibitors
Session 5: Novel methods to measure and control cardiomyocyte function09.00 Measuring the physiological responses of single cardiomyocytes Michiel Helmes (Ionoptix) 09.45 Optogenetic control of cardiac rhythm Claudia Richter (Göttingen, Germany) 10.30 Coffee Break – poster areaSession 6: The immune response and atherogenesis11.00 The roles of T and B cells Giuseppina Caligiuri (Paris, France) 11.45 Targeting immune receptors to reduce atherosclerosis Norbert Gerdes (Düsseldorf, Germany)12.30 Lunch Boxes – Poster area - Meet the facultySession 7: Regenerative medicine13.30 Therapeutic angiogenesis: the long road to translation Seppo Ylä-Herttuala (Kuopio, Finland) 14.15 Bioengineered grafts for the infarcted heart Antoni Bayés Genis (Barcelona, Spain) 15.00 Short breakSession 8: How and why pharma and academia collaborate to develop new medicines15.15 Peter Ferdinandy (Budapest, Hungary) 15.45 Name to be advised17.00-18.30 Poster area – discussion of even-numbered posters, with refreshments
Session 9: Cardiac contractile dysfunction09.00 Cardiometabolic dysregulation, mitochondrial function and arrhythmia Jérémy Fauconnier (Montpellier, France) 09.45 Cardiomyopathies: biology and future treatment options Jolanda van der Velden (Amsterdam, Netherlands) 10.30 Coffee Break – poster areaSession 10: Vulnerable Plaque11.00 The vulnerable plaque – an evolving target? Gerard Pasterkamp (Utrecht, Netherlands)11.45 Imaging the vulnerable plaque to stratify individual patient risk Marc Dweck (Edinburgh, United Kingdom)12.30 Lunch Boxes – Poster area - Meet the facultySession 11: Non-coding RNAs13.30 Control of cardiac remodelling and fibrosis by ncRNAs Paula da Costa Martins (Maastricht, NL) 14.15 Control of angiogenesis and arteriogenesis by miRNAs Yaël Nossent (Leiden, Netherlands) 15.00 Short breakSession 12: Finding new drug targets: the worlds of informatics and omics15.15 The advantages and limitations of proteomics and metabolomics Manuel Mayr (London, United Kingdom)15.45 Using Mendelian randomization to impute causality in genomic studies Jemma Hopewell (Oxford, United Kingdom)17.00-18.30 Poster area – discussion of odd-numbered posters, with refreshments20.30 Participants dinner (Beach party!)
Session 13: Building your career09.00 Advice from the faculty and open discussion10.00 Coffee BreakSession 14: iPS cells and personalised medicine 10.30 iPS cell-derived cardiomyocytes for drug testing Daniel Sinnecker (Munich, DE) 11.15 iPS cell-derived cardiomyocytes to explore gene therapy Jean-Sebastien Hulot (Paris, FR) 12.00 Closing keynote plenary lecture TBC
Discover more about the ESC Council on Basic Cardiovascular Science
Pre-registration is now closed
The selection process has started and if you are selected, we will inform you and send you a link to finalise your registration and payment (by mid-march).
The Summer School 2017 has a limited number of places. If you are accepted, your registration will be considered when payment of 300 Euros is made to the ESC.
Fees for students: 300 Euros (the fee covers course registration, accommodation and breakfast, lunches, 2 evening meals, transport to and from Nice airport and transport between the Novotel Arenas and the European Heart House).
Extras: students will be expected to pay for their flights to Nice Airport and any items not covered in the list above.
The European Heart House Les Templiers2035 Routes des CollesCS 80179 Biot06903 Sophia Antipolis Cedex, France
Jeremy Pearson (UK)
Peter Ferdinandy (HU)
European Society of Cardiology
European Heart HouseLes Templiers2035 Route des CollesCS 80179 BIOT
06903 Sophia Antipolis, FR
© 2017 European Society of Cardiology. All rights reserved